drugset / Trial / NCT01515410
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of this study is to explore the efficacy and tolerability of DM-1992 compared to a standard carbidopa/Levodopa Immediate-Release (CD/LD IR) tablet (Sinemet IR) as measured by: * "ON" time with no dyskinesia or non-troublesome dyskinesia * "OFF" time
Timeline
- Start
- 2012-01
- Primary completion
- 2012-09
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 25 mg | — |
| Subject | Carbidopa | Unknown | 72.5 mg | — |
| Subject | Levodopa | Small molecule | 100 mg | — |
| Subject | Levodopa | Small molecule | 230 mg | — |